Efficacy and Safety of Covid-19 Vaccine in Cardiac Patients
NCT ID: NCT05348629
Last Updated: 2022-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2022-06-01
2023-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assiut University Registry for ACS Patients During COVID-19 Pandemic
NCT04691609
Markers of Atrial Cardiopathay
NCT05623969
Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis
NCT04312490
Pattern of Dyslipidemia Among Patients With Acute Coronary Syndrome at Sohag University Hospital
NCT04951401
Myocarditis After SARS-CoV2-Vaccination
NCT05268458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with age range from 18 to 80 years after 1 month of STEMI .
Exclusion Criteria
* Patients with previous covid infection confirmed by qualitative antibdy test .
* Patients with history of anaphylaxis to any component of the vaccine should not take it .
* patients with febrile illness or acute , ongoing infection .
* immunosuppressive diseases .
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Mina sobhi said fam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mina sobhi said fam
resident doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut University
Asyut, , Egypt
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
covid-19 vaccine
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.